Neutralizing Antibodies Against the Porcine Endogenous Retroviruses (PERVs)
Viruses · 2025
DOI: 10.3390/v17111437 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2025. Verfasst von Jinzhao Ban und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Virology, Free University Berlin, 14163 Berlin, Germany. Hauptthemen laut MEDLINE: Endogenous Retroviruses, Antibodies, Neutralizing, Antibodies, Viral, Retroviridae Infections. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wacker Chemie AG, München, Germany, China Scholarship Council (CSC), Wacker Chemie AG, Munich, Germany.
Abstract (Originalsprache)
Xenotransplantation using pig cells, tissues or organs may be associated with the transmission of porcine zoonotic or xenozoonotic microorganisms. Porcine endogenous retroviruses (PERVs) pose a special risk for xenotransplantation as these viruses can infect human cells and are integrated in multiple copies in the genome of all pigs and, therefore, they cannot be eliminated as other viruses can. To prevent PERV transmission to the recipient, several strategies have been developed: PERV-C-free animals, siRNA and genomic editing. Another strategy is the generation of vaccines based on neutralizing antibodies in order to protect the recipient. To investigate whether a protective vaccine is feasible in the case of PERV, the recombinant transmembrane (p15E) and the surface envelope (gp70) protein of PERV were cloned, produced, purified and used to immunize rats. For the first time, an adjuvant type that is approved for human use was used. In all cases we obtained virus binding antibodies as shown in Western blot assays and neutralizing antibodies as shown in neutralization assays, indicating the potential for a protective vaccine. The epitopes recognized by the antisera against p15E were determined using overlapping peptides. Two main epitopes were found in the sequence of p15E, one in the membrane proximal external region (MPER) and one in the fusion peptide proximal region (FPPR). The epitopes correspond to epitopes determined previously when immunizing different animal species with p15E of PERV. Antibodies against these epitopes block the conformational changes in the transmembrane envelope proteins that are required for membrane fusion, thereby inhibiting infection. The epitope in the MPER is related by sequence and location to an epitope in the transmembrane envelope protein of the human immunodeficiency virus-1 (HIV-1) recognized by a broadly neutralizing antibody from infected patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Virology, Free University Berlin, 14163 Berlin, Germany.
ORCID-Profile: Jinzhao Ban, Benedikt B Kaufer, Joachim Denner
Förderung
- Wacker Chemie AG, München, Germany
- China Scholarship Council (CSC)
- Wacker Chemie AG, Munich, Germany
- Free University Berlin
Zitieren
APA
Ban, J., Krabben, L., Kaufer, B. B., & Denner, J. (2025). Neutralizing Antibodies Against the Porcine Endogenous Retroviruses (PERVs). Viruses. https://doi.org/10.3390/v17111437
Vancouver
Ban J, Krabben L, Kaufer BB, Denner J. Neutralizing Antibodies Against the Porcine Endogenous Retroviruses (PERVs). Viruses. 2025. doi:10.3390/v17111437
BibTeX
@article{Ban2025,
author = {Ban, Jinzhao and Krabben, Ludwig and Kaufer, Benedikt B and Denner, Joachim},
title = {Neutralizing Antibodies Against the Porcine Endogenous Retroviruses (PERVs)},
journal = {Viruses},
year = {2025},
doi = {10.3390/v17111437}
}
EUVIMED